1. The tumor-bearing state induces augmented responses of organ-associated lymphocytes to high-dose interleukin-2 therapy in mice

   • Y. Asano
   • K. Kaneda
   • K. Higashino

   ORIGINAL ARTICLE Pages: 63 - 70

2. Restoration of macrophage tumoricidal activity by bleomycin correlates with the decreased production of transforming growth factor β in rats bearing KDH-8 hepatoma cells

   • L. Yuan
   • Masanobu Kobayashi
   • M. Hosokawa

   ORIGINAL ARTICLE Pages: 71 - 76

3. Treatment of recurrent glioma with intracavitary alloreactive cytotoxic T lymphocytes and interleukin-2

   • C. A. Kruse
   • Linda Cepeda
   • Kevin O. Lillehei

   ORIGINAL ARTICLE Pages: 77 - 87

4. Sequence variation in the monoclonal-antibody-U36-defined CD44v6 epitope

   • Nicole L. W. Van Hal
   • G. A. M. S. Van Dongen
   • R. H. Brakenhoff

   ORIGINAL ARTICLE Pages: 88 - 92

5. Intrapleural instillation of interferon γ in patients with malignant pleurisy due to lung cancer

   • H. Yanagawa
   • Takashi Haku
   • Saburo Sone

   ORIGINAL ARTICLE Pages: 93 - 99

6. Antitumor effects of the combination immunotherapy with interleukin-12 and tumor necrosis factor α in mice

   • W. Lasek
   • Wojciech Feleszko
   • Marek Jakóbisiak

   ORIGINAL ARTICLE Pages: 100 - 108

7. Active and indolent chronic lymphocytic leukaemia – immune and hormonal peculiarities

   • H. Everaus
   • E. Luik
   • Jane Lehtmaa

   ORIGINAL ARTICLE Pages: 109 - 114

8. The antitumor effects of levamisole in mice are mediated by NC-1.1⁺ cells

   • Gregory R. Clarke
   • Robert C. Burton
   • Y. Cheng Smart

   SHORT COMMUNICATION Pages: 115 - 118

9. Active immunization of metastatic melanoma patients with interleukin-2-transduced allogeneic melanoma cells: evaluation of efficacy and tolerability

   • Filiberto Belli
   • Flavio Arienti
   • G. Parmiani

   ERRATUM Pages: 119 - 119